Pharmagen, Inc.
PHRX
Rank in Stocks
#34793
Pharmagen, Inc., a pharmaceutical company located in Silver Spring, Maryland,... Pharmagen, Inc., a pharmaceutical company located in Silver Spring, Maryland, operates primarily as a distributor within the U.S. healthcare market. It provides a diverse range of specialty drugs to various medical clients, including hospitals, acute care centers, surgical facilities, and other healthcare practitioners nationwide. The company's offerings encompass sourcing and distributing specialty pharmaceuticals, blood plasma derivatives, unique medical products, vaccines, anti-infectives, and often hard-to-find medications. A key area of its expertise lies in plasma derivatives, which are vital for managing severe conditions such as cancer, hemophilia, rheumatoid arthritis, multiple sclerosis, blood disorders, hepatitis, and HIV. Additionally, Pharmagen supplies specialized products designed to treat respiratory, oncological, cardiovascular, and hormonal ailments. Beyond its core distribution activities, Pharmagen also produces and sells its own health supplements, notably Clotamin, an over-the-counter multivitamin formulated specifically for individuals undergoing Warfarin therapy. The company further serves its existing customers by supplying traditional pharmaceuticals, including a variety of antibiotics, vaccines, and other oral and injectable medicines. With a specialized focus on drug formulation, Pharmagen Inc. adopted its current name in January 2013, having previously operated as Sunpeaks Ventures, Inc.
Share Price
$0.00001
Last synced: 2026-11-06
Market Cap
$5.17K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Pharmagen, Inc. (PHRX)
Category
Healthcare
EPS for Pharmagen, Inc. (PHRX)
EPS as of March 2014 TTM: $-0.01
According to Pharmagen, Inc.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2026 the company had an EPS of 0, equal to its 2026 EPS of 0.
EPS history for Pharmagen, Inc. from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -38.00% |
| 2013 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $39.05 | -315,019.35% |
US
|
|
| $17.99 | -145,180.65% |
US
|
|
| $7.77 | -62,761.29% |
US
|
|
| $17.99 | -145,180.65% |
US
|
|
| $0.04 | -450.81% |
AU
|
Questions about Pharmagen, Inc.'s earnings per share (EPS)
What is Pharmagen, Inc.'s earnings per share (EPS)?
Pharmagen, Inc.'s earnings per share (EPS) over the last twelve months is $-0.01, as of Mar 2014.
How does Pharmagen, Inc.'s earnings per share (EPS) compare with similar companies?
Pharmagen, Inc.'s earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is McKesson Corporation, with $39.05.